Tuesday, 17 Sep 2019

You are here

Fertility in RA Linked to Disease Activity, NSAIDs and Prednisone

Brouwer and colleagues from the University Medical Center Rotterdam in The Netherlands have studied the issue of infertility in a cohort of RA patients followed prospectively.  The PARA study included 245 women who were enrolled preconception or during the first trimester.

The primary outcome was a delay in the time to pregnancy (TTP), meaning >12 months to conceive. TTP was seen in 42% of 245 RA women followed. Longer TTP was related to age, nulliparity, disease activity, and preconception NSAID or prednisone use. Thus there was a 19% prolongation of TTP per point increase in DAS28. The impact of prednisone use was dose dependent, with significantly longer TTP when daily dose was >7.5 mg.

Factors not associated with infertility included smoking, disease duration, rheumatoid factor, anti-citrullinated protein antibodies, past methotrexate use, and preconception sulfasalazine.

Infertility is more prevalent in RA patients who are older or nulliparous, have higher disease activity, use NSAIDs or use prednisone >7.5 mg daily.

Optimal control of disease activity is necessary for those wishing to become pregnant.  The possible negative effects of NSAIDs use and higher prednisone doses should be considered as well.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Checkpoint Inhibitors: Who Gets Myocarditis?

The usual risk factors for myocarditis may not apply to who gets it while on immune checkpoint inhibiting cancer drugs, an FDA adverse event database suggested.

NSAIDs Mediate Cardiovascular Risk in OA

NSAIDs have been linked to an increased risk of cardiovascular disease, but does this also hold for osteoarthritis (OA) patients.

Tofacitinib Gets a New Boxed Warning for Blood Clots and Death with Higher Doses

The U.S. Food and Drug Administration has approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis. 

EHR-Related Adverse Events Usually Involve Medications

Concerns about the unintended risks inherent in electronic health records (EHR) by analysis of EHR–related harms identified from large database of malpractice suits and claims; they found that EHR related adverse events exist, and may be associated with an severe harms and uncommonly, death.

Methotrexate Use Not Linked to Interstitial Lung Disease in RA

People with rheumatoid arthritis have a significant risk of developing interstitial lung disease (RA-ILD), yet there is often a question as to whether methotrexate (MTX) exposure can cause or worsen ILD.  A controlled cohort study suggests that MTX use is not associated with an increased risk of RA-ILD and instead, there is evidence suggesting MTX use may delay the onset of ILD.